Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays
Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug discovery, development, testing, and manufacturing…
UBS and Citi Are Bullish on Royalty Pharma Plc (RPRX) - Here's Why
Royalty Pharma Plc (NASDAQ: RPRX) is one of the best healthcare stocks under $50 to invest in. On January 30, Royalty Pharma Plc (NASDAQ:RPRX) was upgraded to Buy from Neutral by UBS, with the firm raising the price target on the stock to $49 from…
Sanofi CEO: The enterprise AI shift will reshape pharma in 2026
At Davos this year, AI was a key pillar of discussion. Increasingly, people recognize the impact it is already having on innovation and growth. I believe that we will see in the months ahead companies in all sectors proving that AI is not a…
New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.
New to The Street, the nationally syndicated, long-form television and digital media platform, today announced it has signed a six-part media series with Medicus Pharma Ltd. (NASDAQ:MDCX) ('Medicus' or the 'Company'), a precision guided…
'We fought monopoly, not science': Pharma leaders debate India's future
4 min read Mumbai Make us preferred source on Google “We fought against monopoly, not science,” said Dr Yusuf Hamied of Cipla, recalling how Indian drugmakers campaigned for the Patents Act of 1972. He described telling then Prime…
US-Bangladesh pact unlikely to impact India's pharma, medtech exports
The United States and Bangladesh have finalised a bilateral reciprocal trade agreement aimed at deepening economic ties, but industry executives say it is unlikely to materially impact India's pharmaceutical and medical device exports, despite…
JM Financial flags growth concerns in Mankind Pharma; initiates with Reduce
Domestic brokerage JM Financial has initiated coverage on pharmaceutical company Mankind Pharma with a 'Reduce' rating, citing moderating growth in its core India business, high exposure to slow-growing and mature therapies, and limited scope for a…
Lupin settles dispute with Astellas Pharma, keeps Mirabegron sales in US
Under the agreement, Lupin and its US unit will pay Astellas $90 million, including a $75 million upfront payment and per-unit licensing fees on Mirabegron sales through September 2027 | Photo: X@LupinGlobal 1 min read Last Updated: Feb 10 2026 |…
Aurobindo Pharma sinks 8%, stock hits over 3-month low post Q3 results
Share price of Aurobindo Pharma hit an over three-month low at ₹1,110.55, falling 8 per cent on the BSE in Tuesday's intra-day trade after the company announced December 2025 quarter (Q3FY26) results on Monday after market hours. The stock…
Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US
Indian drugmaker Lupin said on Tuesday it has settled a patent infringement dispute with Japan's Astellas Pharma over the bladder disorder drug Mirabegron, allowing it to continue selling the product in the…
Ascendis Pharma A/S $ASND Shares Sold by Candriam S.C.A.
Candriam S.C.A. reduced its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 8.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional…
CorMedix Investor Day: Melinta Deal Fuels Shift to Multi-Product Pharma, Rezzayo Q2 Data Ahead
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 CorMedix NASDAQ: CRMD used its 2026 Analyst and Investor Day to outline its shift from a single-product renal-focused company to what management described as a diversified…
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of 'Moderate Buy' by Analysts
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) has been assigned an average rating of 'Moderate Buy' from the twenty-three research firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the…
Allianz Asset Management GmbH Sells 127,319 Shares of Royalty Pharma PLC $RPRX
Allianz Asset Management GmbH reduced its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 35.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 235,227…
Pearl Global Industries Ltd leads losers in 'A' group
Kiri Industries Ltd, Gokaldas Exports Ltd, Aurobindo Pharma Ltd and Kitex Garments Ltd are among the other losers in the BSE's 'A' group today, 10 February 2026. Kiri Industries Ltd, Gokaldas Exports Ltd, Aurobindo Pharma Ltd and Kitex Garments Ltd…
Receive a Daily briefing on Pharma Industry News
Get Started